Moderna's Melanoma Vaccine Cuts Cancer Return Risk

A new personalized cancer vaccine using mRNA technology has shown remarkable results in preventing melanoma from returning after surgery.

The breakthrough could open doors for similar treatments across dozens of other cancers.